Table 4. Risk of 30 day Mortality for Women Compared with Men, Following ACS in the Cohort with Angiographic Data (n=35,128).
Event Rates | Odds Ratio (Confidence Interval) | |||
---|---|---|---|---|
Women | Men | Unadjusted | Adjusted† | |
All ACS | 354/9375 3.8% |
625/25653 2.4% |
1.57 (1.38, 1.79) | 0.96 (0.77, 1.18) |
STEMI | 230/4771 4.8% |
355/15506 2.3% |
2.16 (1.83, 2.56)* | 1.23 (0.96, 1.57)* |
NSTEMI | 61/1770 3.5% |
135/4966 2.7% |
1.28 (0.94, 1.74)* | 0.76 (0.53, 1.10)* |
Unstable Angina | 63/2834 2.2% |
135/5181 2.6% |
0.85 (0.62, 1.15)* | 0.65 (0.46, 0.93)* |
Abbreviations, as above
Odds ratios of female vs. male and 95% CI obtained through logistic regression including the following covariates (age, Killip class, interaction between age and Killip class, heart rate, systolic blood pressure, weight, height, history of CHF, history of MI, history of CABG, history of diabetes, history of PCI, history of hypertension, current smoking status, and former smoking status) along with type of ACS and angiographic disease severity
Includes ACS*sex interaction to obtain the sex effect conditional on ACS categories
There was no significant difference in overall mortality at 30 days between women and men under the Bonferroni-adjusted significance level 0.005 (= .05/10)